Multidrug resistance has become a common phenomenon leading to difficulty in infection control. No options are left to treat such infections after the emergence of colistin resistance. Therefore, this approach to developing multi-epitope therapeutic vaccines is very promising to face the challenge of infection control. This study is based on comparative pan-genomic and subtractive proteomic analyses of 30 proteomes, which provide a wider range of proteins to select multiple epitopes for effective vaccine.
Afshan et al. (Fri,) studied this question.